The diagnosis of interstitial lung disease (ILD) can be difficult, especially in the early stages when pulmonary function tests (PFTs) show only minor changes. To improve the effectiveness of early diagnosis, researchers wanted to evaluate the potential of artificial intelligence (AI)-based software to support pulmonary specialists in analyzing PFT results.
Autoren
- Jens Dehn
Publikation
- InFo PNEUMOLOGIE & ALLERGOLOGIE
Related Topics
You May Also Like
- HER2+ early breast cancer
DESTINY-Breast11 – neoadjuvant T-DXd without anthracyclines
- Lavender aromatherapy
Take away the fear of the dentist
- Digital dermatology: innovative project examples
AI and eHealth tools in HS care
- Mantle cell lymphoma
Recurrence after BTK inhibition – prognostic factors and treatment options
- Dementia risk with type 2 diabetes
SGLT2 inhibitors with advantages vs. DPP4 inhibitors
- T helper 1 cells
Differentiation and activation of Th1 cells – a multi-omics approach
- Cannabis for schizophrenia
CBD pre-treatment could exacerbate side effects
- Type 2 diabetes: cardiovascular risk reduction is realistic